Lepu Biopharma Co Ltd
HKEX:2157
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Husqvarna AB
STO:HUSQ B
|
SE |
|
N
|
Nexus Minerals Ltd
ASX:NXM
|
AU |
|
Ayala Land Inc
OTC:AYAAF
|
PH |
|
Boyaa Interactive International Ltd
HKEX:434
|
CN |
Lepu Biopharma Co Ltd
Other Items
Lepu Biopharma Co Ltd
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
L
|
Lepu Biopharma Co Ltd
HKEX:2157
|
Other Items
¥0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Other Items
¥1B
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Other Items
¥1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
RemeGen Co Ltd
SSE:688331
|
Other Items
-¥5.6m
|
CAGR 3-Years
61%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
Akeso Inc
HKEX:9926
|
Other Items
-¥2.7B
|
CAGR 3-Years
-214%
|
CAGR 5-Years
-90%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
|
Other Items
-¥740.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Lepu Biopharma Co Ltd
Glance View
Lepu Biopharma Co., Ltd. operates as an an innovation-driven biopharmaceutical company. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2022-02-23. The firm mainly develops product lines of tumor candidate drugs, including antibody drug conjugate (ADC), oncolytic virus drug products and immunotherapy at clinical and pre-clinical stages. The Company’s major pipeline assets consist of MRG003, MRG002, HX008 and LP002, and three key clinical-stage drug candidates. The firm's products are sold at home and abroad.
See Also
What is Lepu Biopharma Co Ltd's Other Items?
Other Items
0
CNY
Based on the financial report for Dec 31, 2025, Lepu Biopharma Co Ltd's Other Items amounts to 0 CNY.
